Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

This study has been completed.

Sponsor:

Collaborator:

Information provided by (Responsible Party):

National Cancer Institute (NCI) ( NCIC Clinical Trials Group )

ClinicalTrials.gov Identifier:

NCT00099060

First received: December 8, 2004

Last updated: May 16, 2013

Last verified: April 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2011
Primary Completion Date:	January 2011 (Final data collection date for primary outcome measure)